These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28886134)

  • 1. Clinical utility of the modified Glasgow prognostic score in lung cancer: A meta-analysis.
    Jin J; Hu K; Zhou Y; Li W
    PLoS One; 2017; 12(9):e0184412. PubMed ID: 28886134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of the Glasgow prognostic score in lung cancer: evidence from 10 studies.
    Jin J; Hu K; Zhou Y; Li W
    Int J Biol Markers; 2018 May; 33(2):201-207. PubMed ID: 29076522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high Glasgow prognostic score (GPS) or modified Glasgow prognostic score (mGPS) predicts poor prognosis in gynecologic cancers: a systematic review and meta-analysis.
    Nie D; Zhang L; Wang C; Guo Q; Mao X
    Arch Gynecol Obstet; 2020 Jun; 301(6):1543-1551. PubMed ID: 32409927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of the Glasgow Prognostic Score or Modified Glasgow Prognostic Score for Patients with Colorectal Cancer Receiving Various Treatments: a Systematic Review and Meta-Analysis.
    He L; Li H; Cai J; Chen L; Yao J; Zhang Y; Xu W; Geng L; Yang M; Chen P; Zheng J; Yang Y; Gong S
    Cell Physiol Biochem; 2018; 51(3):1237-1249. PubMed ID: 30481755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Significance of the Modified Glasgow Prognostic Score in Patients With Pancreatic Cancer: A Meta-Analysis.
    Fu W; Wang K; Yan S; Wang X; Tang B; Chang J; Wang R; Wu T
    Dose Response; 2020; 18(3):1559325820942065. PubMed ID: 32821253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of modified Glasgow prognostic score in patients with esophageal squamous cell cancer: a Meta-analysis.
    Wang Y; Chen L; Wu Y; Li P; Che G
    Nutr Cancer; 2020; 72(7):1146-1154. PubMed ID: 31617767
    [No Abstract]   [Full Text] [Related]  

  • 7. Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis.
    Qi F; Xu Y; Zheng Y; Li X; Gao Y
    Ann Transl Med; 2019 Oct; 7(20):531. PubMed ID: 31807513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comprehensive analysis of Glasgow Prognostic Score (GPS)/the modified Glasgow Prognostic Score (mGPS) on immune checkpoint inhibitor efficacy among patients with advanced cancer.
    Zhang Y; Chen S; Chen H; Li W
    Cancer Med; 2023 Jan; 12(1):38-48. PubMed ID: 35702873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Value of Pretreatment Glasgow Prognostic Score/Modified Glasgow Prognostic Score in Ovarian Cancer: A Systematic Review and Meta-Analysis.
    Xu S; Song L; Liu X
    Nutr Cancer; 2022; 74(6):1968-1975. PubMed ID: 34549675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic and clinical significance of modified glasgow prognostic score in pancreatic cancer: a meta-analysis of 4,629 patients.
    Wu D; Wang X; Shi G; Sun H; Ge G
    Aging (Albany NY); 2021 Jan; 13(1):1410-1421. PubMed ID: 33406501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of preoperative modified Glasgow prognostic score in surgical non-small cell lung cancer: A meta-analysis.
    Yang C; Ren G; Yang Q
    Front Surg; 2022; 9():1094973. PubMed ID: 36700011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Utility of the Modified Glasgow Prognostic Score in Urothelial Carcinoma: Outcomes from a Pooled Analysis.
    Tan D; Li J; Lin T; Tan P; Zhang J; Xiong Q; Jiang J; Li Y; Zhang P; Wei Q
    J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic value of modified Glasgow Prognostic Score in pancreatic cancer: a meta-analysis.
    Zhang H; Ren D; Jin X; Wu H
    Cancer Cell Int; 2020; 20():462. PubMed ID: 32982584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic value of C-reactive protein to albumin ratio in patients with lung cancer.
    Deng TB; Zhang J; Zhou YZ; Li WM
    Medicine (Baltimore); 2018 Dec; 97(50):e13505. PubMed ID: 30558004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of preoperative high-sensitivity modified Glasgow prognostic score in advanced colon cancer: a retrospective observational study.
    Kasahara K; Enomoto M; Udo R; Tago T; Mazaki J; Ishizaki T; Yamada T; Nagakawa Y; Katsumata K; Tsuchida A
    BMC Cancer; 2022 Jan; 22(1):20. PubMed ID: 34980009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified Glasgow prognostic score might be a prognostic factor for hepatocellular carcinoma: a meta-analysis.
    Chen H; Hu N; Chang P; Kang T; Han S; Lu Y; Li M
    Panminerva Med; 2017 Dec; 59(4):302-307. PubMed ID: 28001023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glasgow prognostic score as a prognostic factor in metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy.
    Linton A; Pond G; Clarke S; Vardy J; Galsky M; Sonpavde G
    Clin Genitourin Cancer; 2013 Dec; 11(4):423-30. PubMed ID: 23816526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Meta-Analysis of Glasgow Prognostic Score and Modified Glasgow Prognostic Score as Biomarkers for Predicting Survival Outcome in Renal Cell Carcinoma.
    Tong T; Guan Y; Xiong H; Wang L; Pang J
    Front Oncol; 2020; 10():1541. PubMed ID: 33042799
    [No Abstract]   [Full Text] [Related]  

  • 19. Utility of High-Sensitivity Modified Glasgow Prognostic Score in Cancer Prognosis: A Systemic Review and Meta-Analysis.
    Wu TH; Tsai YT; Chen KY; Yap WK; Luan CW
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of the Glasgow prognostic score in colorectal cancer: a meta-analysis of 9,839 patients.
    Lu X; Guo W; Xu W; Zhang X; Shi Z; Zheng L; Zhao W
    Cancer Manag Res; 2019; 11():229-249. PubMed ID: 30636896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.